Discover a New Microfluidic System from MilliporeSigma at AACR

10 Apr 2016
Lynsey Forsyth
Post Doc / Research Fellow

Learn how to gain unprecedented control of your cell culture micro-environment using the new CellASIC® ONIX2 Microfluidic System.

Plus, visit MilliporeSigma at booth #528 to learn about all the latest tools for cancer research and care.

Including:

  • Pre-designed & Custom CRISPRs
  • Duolink® & PLA® Technology
  • ELISA
  • Western Blot Analysis
  • Comprehensive Antibody Portfolio
  • Gene Expression
  • Cell Culture
  • Our Exhibitor Spotlight Theater Presentation
  • A schedule of our poster sessions
  • Chance to win a Fitbit

About MilliporeSigma

MilliporeSigma, the U.S. life science business of Merck KGaA, Darmstadt, Germany is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. For more information, please visit www.emdgroup.com.

Links

Tags